Search for: "Ely Lilly"
Results 1421 - 1440
of 2,157
Sorted by Relevance
|
Sort by Date
9 Nov 2009, 6:01 am
. $7 Billion in Penalties Since May 2004, Pfizer, Eli Lilly & Co., Bristol-Myers Squibb Co. and four other drug companies have paid a total of $7 billion in fines and penalties. [read post]
23 Jan 2013, 1:55 pm
Eli Lilly, the 2010 en banc Federal Circuit decision that reaffirmed that the written description requirement is separate from enablement, which is probably the first case I would want to look to (and which occupies a substantial portion of Chisum § 7.04, the section on the written description requirement). [read post]
1 Dec 2017, 6:20 am
The Swiss Federal Patent court had originally denied the infringement of Eli Lilly's patent but the Supreme Court granted Eli Lilly, a remarkable event in itself. [read post]
17 May 2021, 12:45 am
The DutchKat taking some timein her box to focus on just one thing - the latest half-year patent review (and her pink jingle ball)Last year the IPKat started a series recapping patent litigation in some of the major patent litigation jurisdictions in Europe (see reports from the Netherlands, Germany and France). [read post]
15 Mar 2007, 6:33 am
Eli Lilly & Co., 2006 WL 2168831, at *3 (D. [read post]
17 Jun 2012, 3:52 pm
Robyn Orth is a consultant covering digital government affairs at Eli Lilly and Company. [read post]
23 Feb 2011, 10:18 pm
Eli Lilly, 119 F.3d at 1568. [read post]
24 Dec 2009, 12:28 am
In dismissing the breach of express warranty claim, the judge said the fund didn't directly receive any express warranties from Eli Lilly. [read post]
8 Apr 2010, 5:21 pm
Eli Lilly & Co. v. [read post]
1 Oct 2011, 12:40 pm
He tries to parse the abominal Seventh Circuit case Eli Lilly v. [read post]
27 Apr 2009, 9:43 am
Eli Lilly & Co., 25 No. 3 Andrews Pharmaceutical Litig. [read post]
7 Jul 2008, 10:59 am
Eli Lilly & Co., No. 181/07, Ontario Superior Court of Justice, Divisional Court (Toronto) (July 2, 2008). [read post]
6 Jan 2010, 2:05 pm
From a December 23, 2009 Bloomberg article, "Amylin Falls as Analyst Says FDA Wants Byetta Study", by reporter Rob Waters: San Diego-based Amylin and Indianapolis-based Eli Lilly & Co., which co-market the drug, announced Oct. 30 that the Food and Drug Administration had cleared the drug for use as standalone therapy for Type 2 diabetics and that prescribing information would warn about the risk of pancreatitis, an inflamed pancreas, in patients with severe… [read post]
19 Sep 2009, 9:54 am
Pfizer said in the motion that Egilman had previously been sanctioned by a federal judge in New York for disclosing confidential documents in lawsuits brought against Eli Lilly & Co. over its antipsychotic medication Zyprexa. [read post]
11 Sep 2015, 4:00 am
For example, in a motion for an interlocutory injunction sought by Pfizer against the introduction of CIALIS by Eli Lilly (see 2004 FC 223), Justice Blais summarized the evidence and held, “I am not convinced that the plaintiff will suffer irreparable harm since the losses that Pfizer will incur by sharing the market with Lilly are reasonably calculable, and the other harm claimed by Pfizer is entirely of a speculative nature. [read post]
17 Feb 2008, 10:32 pm
The court thus denied plaintiff's motion to remand.Judge Weinstein rejected Eli Lilly's alternative ground for exercising federal jurisdiction -- that federal law and FDA regulations preempted the state law claims. [read post]
13 Nov 2014, 11:26 am
In the 6th Actos trial earlier in the year, there was a massive $9 billion verdict handed down in Louisiana against Takeda and Eli Lilly & Co. for hiding the diabetes medicine’s cancer risks. [read post]
15 Jun 2023, 7:00 am
In two separate lawsuits, both Eli Lilly and Novo Nordisk argued that a requirement to deliver 340B discounted drugs to contract pharmacies without restrictions is an unconstitutional taking. [read post]
28 Sep 2011, 1:56 am
(Kluwer Patent Blog) Gabitril (Tiagabine) – US: Cephalon files suits against Sun Pharma. in New Jersey and Michigan in response to Para IV certification (Patent Docs) Glivec (Imatinib) – India: Novartis Glivec patent case: preliminary objection (Spicy IP) Lovenox (Enoxaparin) – US: Momenta files patent infringement complaint against Amphastar in response to impending launch of generic Lovenox (Patent Docs) Lumigan (Bimatoprost) – US: Validity of Allergan Lumigan patents… [read post]
1 Apr 2008, 10:57 am
Whether the trial court erroneously interpreted Thomas's Third Commercial Guaranty when calculating the damage award.In Eli Lilly and Company and Mark Hughes v. [read post]
